These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1372 related items for PubMed ID: 18191732

  • 1. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO, Grzeslo A, Witkowski T, Mandal AK, Slater RM, Roughton M, Foldes G, Thum T, Majda J, Banasiak W, Missouris CG, Poole-Wilson PA, Anker SD, Ponikowski P.
    J Am Coll Cardiol; 2008 Jan 15; 51(2):103-12. PubMed ID: 18191732
    [Abstract] [Full Text] [Related]

  • 2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 3. Intravenous iron alone for the treatment of anemia in patients with chronic heart failure.
    Bolger AP, Bartlett FR, Penston HS, O'Leary J, Pollock N, Kaprielian R, Chapman CM.
    J Am Coll Cardiol; 2006 Sep 19; 48(6):1225-7. PubMed ID: 16979010
    [Abstract] [Full Text] [Related]

  • 4. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators.
    N Engl J Med; 2009 Dec 17; 361(25):2436-48. PubMed ID: 19920054
    [Abstract] [Full Text] [Related]

  • 5. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
    Okonko DO, Mandal AK, Missouris CG, Poole-Wilson PA.
    J Am Coll Cardiol; 2011 Sep 13; 58(12):1241-51. PubMed ID: 21903058
    [Abstract] [Full Text] [Related]

  • 6. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI, Zueva EB, Silverberg DS, Shaked M.
    J Nephrol; 2008 Sep 13; 21(2):236-42. PubMed ID: 18446719
    [Abstract] [Full Text] [Related]

  • 7. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.
    Ponikowski P, Anker SD, Szachniewicz J, Okonko D, Ledwidge M, Zymlinski R, Ryan E, Wasserman SM, Baker N, Rosser D, Rosen SD, Poole-Wilson PA, Banasiak W, Coats AJ, McDonald K.
    J Am Coll Cardiol; 2007 Feb 20; 49(7):753-62. PubMed ID: 17306703
    [Abstract] [Full Text] [Related]

  • 8. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec 20; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 9. A pilot evaluation of the long-term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio-renal anemia syndrome: influence on neurohormonal activation and clinical outcomes.
    Comín-Colet J, Ruiz S, Cladellas M, Rizzo M, Torres A, Bruguera J.
    J Card Fail; 2009 Nov 20; 15(9):727-35. PubMed ID: 19879457
    [Abstract] [Full Text] [Related]

  • 10. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
    Beck-da-Silva L, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N.
    J Card Fail; 2007 Feb 20; 13(1):14-7. PubMed ID: 17338998
    [Abstract] [Full Text] [Related]

  • 11. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M, Silverberg DS, Bits I, Steinbruch S, Wexler D, Sheps D, Schwartz D, Oksenberg A.
    Am Heart J; 2007 Nov 20; 154(5):870-6. PubMed ID: 17967592
    [Abstract] [Full Text] [Related]

  • 12. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G, Amaral N, Sleigh A, Ayis S, Catibog N, McDonagh T, Monaghan M, Amin-Youssef G, Kemp GJ, Shah AM, Okonko DO.
    Circulation; 2019 May 21; 139(21):2386-2398. PubMed ID: 30776909
    [Abstract] [Full Text] [Related]

  • 13. Are hematinic deficiencies the cause of anemia in chronic heart failure?
    Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL.
    Am Heart J; 2004 May 21; 147(5):924-30. PubMed ID: 15131553
    [Abstract] [Full Text] [Related]

  • 14. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.
    Beck-da-Silva L, Piardi D, Soder S, Rohde LE, Pereira-Barretto AC, de Albuquerque D, Bocchi E, Vilas-Boas F, Moura LZ, Montera MW, Rassi S, Clausell N.
    Int J Cardiol; 2013 Oct 09; 168(4):3439-42. PubMed ID: 23680589
    [Abstract] [Full Text] [Related]

  • 15. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.
    Van Craenenbroeck EM, Conraads VM, Greenlaw N, Gaudesius G, Mori C, Ponikowski P, Anker SD.
    Eur J Heart Fail; 2013 Jul 09; 15(7):756-62. PubMed ID: 23639779
    [Abstract] [Full Text] [Related]

  • 16. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial.
    Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A.
    Obstet Gynecol; 2005 Dec 09; 106(6):1335-40. PubMed ID: 16319260
    [Abstract] [Full Text] [Related]

  • 17. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan 09; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR.
    Arzneimittelforschung; 2010 Jan 09; 60(6a):386-98. PubMed ID: 20648930
    [Abstract] [Full Text] [Related]

  • 19. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F.
    J Nephrol; 2000 Jan 09; 13(6):444-9. PubMed ID: 11132761
    [Abstract] [Full Text] [Related]

  • 20. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT.
    Transfusion; 2009 Dec 09; 49(12):2719-28. PubMed ID: 19682342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.